Table 1. Study Population.
| Patient Characteristics | PKDL (n = 34) | Healthy controls (n = 15) |
|---|---|---|
| Age (years) range (Mean ± SEM) | 9–80 (32.94 ± 2.76) | 23–33 (27.70 ± 92) |
| Sex (Male/Female) | 7.5:1 | 2:1 |
| Cases reporting history of VL | 26 | None |
| History of VL, range in years (Mean ± SEM) | 0.5–42 (6.97± 1.90) | N.A |
| Duration of disease, range in years (Mean ± SEM) | 0.3–20 (5.30 ± 0.87) | N.A |
| Lesional profile | ||
| (i) Polymorphic | 30 | N.A. |
| (ii) Macular | 4 | N.A. |
| Hemoglobin (g/dl) | 11.96 ± 0.89 | 12.82 ± 0.57 |
| Total leukocyte count (cells/mm3) | 6836 ± 552.20 | 7560 ± 535.40 |
| Differential leukocyte count (%) | ||
| (i) Neutrophils | 60.6 ± 1.9 | 68.2 ± 2.2 |
| (ii) Lymphocytes | 32.1 ± 1.5 | 28.2 ± 2.4 |
| (iii) Monocytes | 2.1 ± 0.5 | 1.4 ± 0.2 |
| (iv) Eosinophils | 4.9 ± 0.7* | 2.2 ± 0.4 |
| (v) Basophils | 0.8 ± 0.5 | 0.00 |
Values are mean ± SEM.
N.A = Not Applicable
*indicates p<0.05 than healthy controls